Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan in Uterine Fibroids (ASTEROID 3)
NCT03400943Phase 3Terminated
- Sponsor
- Bayer
- Start
- Jan 2018
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 3 trial of vilaprisan in Uterine Fibroids (UF), sponsored by Bayer. Started Jan 2018; status: terminated.
02
Drugs
vilaprisan
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT03400943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03400943.